Category Archives: Pfizer to raise R&D spending to bolster pipeline: An odd move since their blockbuster drugs are acquired through acquisitions

Pfizer to raise R&D spending to bolster pipeline: An odd move since their blockbuster drugs are acquired through acquisitions

Comment by Jim Campbell This is an odd move for Pfizer whose research pipeline has produced next to nothing. Disclosure: I never worked a day for Pfizer.     All marketed drugs picked up by their usual M.O. buying out … Continue reading

Posted in Pfizer to raise R&D spending to bolster pipeline: An odd move since their blockbuster drugs are acquired through acquisitions | Tagged , , , , , , | Leave a comment